Journal Mobile Options
Table of Contents
Vol. 77, No. 3, 2006
Issue release date: October 2006
Section title: Original Paper
Urol Int 2006;77:269–274
(DOI:10.1159/000094821)

Pumpkin Seed Oil and Phytosterol-F Can Block Testosterone/Prazosin-Induced Prostate Growth in Rats

Tsai Y.-S. · Tong Y.-C. · Cheng J.-T. · Lee C.-H. · Yang F.-S. · Lee H.-Y.
aInstitute of Clinical Medicine and Departments of bUrology and cPharmacology, College of Medicine, National Cheng Kung University, and dCentral R & D Institute, Uni-President Enterprises Corp., Tainan, Taiwan

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restriction apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Automatic perpetual access to all articles of the subscribed year(s)
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 8/30/2005
Accepted: 12/21/2005
Published online: 10/11/2006

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN

Abstract

Introduction: This study was undertaken to investigate the effects of pumpkin seed oil alone or combined with Phytosterol-F on testosterone/prazosin-induced (T-P) prostate growth in rats. Materials and Methods: Forty adult Wistar rats were divided into five groups, including: one control group, rats treated with vehicle only, one group treated with T-P, and two groups of T-P-treated rats, one receiving orally pumpkin seed oil alone and one group receiving orally pumpkin seed oil combined with Phytosterol-F. Two weeks later, the prostatic weight-to-body weight ratio was determined after sacrifice. The total protein concentration was measured by using a protein assay. Some ventral prostatic tissues were histologically examined after hematoxylin-eosin staining. Results: Histological sections of the ventral prostate showed that the architecture of the prostate glands became hyperplastic in the T-P rats, but not in the control or vehicle-treated animals. As compared with the control or vehicle group, T-P rats had a significantly higher prostatic weight-to-body weight ratio for the ventral prostate (p = 0.05 and p = 0.007, respectively), but not for the dorsolateral prostate (p = 0.53 and p = 0.73, respectively). The T-P rats had significantly higher protein levels within both lobes (ventral lobe, p = 0.02 and p < 0.0001, respectively; dorsolateral lobe, p = 0.06 and p = 0.005, respectively). As compared with the T-P-alone rats, the TP rats treated with pumpkin seed oil alone or pumpkin seed oil combined with Phytosterol-F had a significantly lower weight ratio for the ventral prostate (p = 0.01 and p = 0.004, respectively) and significantly lower protein levels within both lobes (p = 0.03 and p = 0.003, respectively; p = 0.007 and p = 0.002, respectively). In addition, Phytosterol-F had some additive effect on the total protein synthesis within the ventral prostate (p = 0.02). Conclusion: Pumpkin seed oil alone or combined with Phytosterol-F can block the T-P-induced increases in prostatic weight-to-body weight ratio and protein synthesis.


Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: 8/30/2005
Accepted: 12/21/2005
Published online: 10/11/2006

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0

ISSN: 0042-1138 (Print)
eISSN: 1423-0399 (Online)

For additional information: http://www.karger.com/UIN


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Bales GT, Christiano AP, Kirsh EJ, Gerber G: Phytotherapeutic agents in the treatment of lower urinary tract symptoms: a demographic analysis of awareness and use at the University of Chicago. Urology 1999;54:86–89.
  2. Lowe FC, Fagelman E: Phytotherapy in the treatment of benign prostatic hyperplasia: an update. Urology 1999;53:671–678.
  3. Buck AC: Phytotherapy for the prostate. Br J Urol 1996;78:325–336.
  4. Carbin BE, Larsson B, Lindahl O: Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol 1990;66:639–641.
  5. Kadow C, Abrams PH: A double-blind trial of the effect of beta-sitosteryl glucoside (WA 184) in the treatment of benign prostatic hyperplasia. Eur Urol 1986;12:187–189.
  6. Donkervoort T, Sterling A, van Ness J, Donker PJ: A clinical and urodynamic study of tadenan in the treatment of benign prostatic hypertrophy. Eur Urol 1977;3:218–225.
  7. Champault G, Patel JC, Bonnard AM: A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. Br J Clin Pharmacol 1984;18:461–462.
  8. Reece Smith H, Memon A, Smart CJ, Dewbury K: The value of Permixon in benign prostatic hypertrophy. Br J Urol 1986;58:36–40.
  9. Descotes JL, Rambeaud JJ, Deschaseaux P, Faure G: Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders. Clin Drug Invest 1995;9:291–297.

    External Resources

  10. Buck AC, Cox R, Rees RW, Ebeling L, John A: Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, Cernilton. A double-blind, placebo-controlled study. Br J Urol 1990;66:398–404.
  11. Dreikorn K, Borkowski A, Braeckman J, et al: Other medical therapies; in Denis L, Griffiths K, Murphy G (eds): Proc Fourth Int Consultation on Benign Prostatic Hyperplasia. Plymouth, Health Publications, 1998, pp 635–659.
  12. Lowe FC, Ku JC: Phytotherapy in treatment of benign prostatic hyperplasia: a critical review. Urology 1996;48:12–20.
  13. Lowe FC, Dreikorn K, Borkowski A, Braeckman J, Denis L, Ferrari P, Gerber G, Levin R, Perrin P, Senge T: Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH. Prostate 1998;37:187–193.
  14. Hatzichristou DG, Constantinou CE: Adrenergic and hormonal stimulation produces an increase in the prostate and bladder weight. Neurourol Urodyn 1995;14:467–469.
  15. Lee JZ, Omata S, Tillig B, Perkash I, Constantinou CE: Chronology and urodynamic characterization of micturition in neurohormonally induced experimental prostate growth in the rat. Neurourol Urodyn 1998;17:55–69.
  16. Paubert-Braquet M, Richardson FO, Servent-Saez N, Gordon WC, Monge MC, Bazan NG, Authie D, Braquet P: Effect of Serenoa repens extract (Permixon®) on estradiol/testosterone-induced experimental prostate enlargement in the rat. Pharmacol Res 1996;34:171–179.
  17. Rhodes L, Primka RL, Berman C, Vergult G, Gabriel M, Pierre-Malice M, Gibelin B: Comparison of finasteride (Proscar®), a 5α-reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5α-reductase inhibition. Prostate 1993;22:43–51.
  18. Huggins CB, Stevens RA: The effect of castration on benign hypertrophy of the prostate in man. J Urol 1940;43:105–110.
  19. Lee C, Sensibar JA: Proteins of the rat prostate. II. Synthesis of new proteins in the ventral lobe during castration-induced regression. J Urol 1987;138:903–908.
  20. Sensibar JA, Alger B, Tseng A, Berg L, Lee C: Proteins of the rat prostate. III. Effect of testosterone on protein synthesis by the ventral prostate of castrated rats. J Urol 1990;143:161–166.
  21. Abate-Shen C, Shen MM: Molecular genetics of prostate cancer. Genes Dev 2000;14:2410–2434.
  22. Zuhair HA, Abd el-Fattah AA, El-Sayed MI: Pumpkin-seed oil modulates the effect of felodipine and captopril in spontaneously hypertensive rats. Pharmacol Res 2000;41:555–563.
  23. al-Zuhair H, Abd el-Fattah AA, Abd el Latif HA: Efficacy of simvastatin and pumpkin-seed oil in the management of dietary-induced hypercholesterolemia. Pharmacol Res 1997;35:403–408.